全文获取类型
收费全文 | 13310篇 |
免费 | 704篇 |
国内免费 | 77篇 |
专业分类
耳鼻咽喉 | 74篇 |
儿科学 | 268篇 |
妇产科学 | 327篇 |
基础医学 | 1783篇 |
口腔科学 | 500篇 |
临床医学 | 1136篇 |
内科学 | 3720篇 |
皮肤病学 | 328篇 |
神经病学 | 1317篇 |
特种医学 | 324篇 |
外科学 | 1692篇 |
综合类 | 59篇 |
一般理论 | 2篇 |
预防医学 | 700篇 |
眼科学 | 191篇 |
药学 | 801篇 |
中国医学 | 35篇 |
肿瘤学 | 834篇 |
出版年
2023年 | 96篇 |
2022年 | 211篇 |
2021年 | 442篇 |
2020年 | 221篇 |
2019年 | 292篇 |
2018年 | 432篇 |
2017年 | 266篇 |
2016年 | 341篇 |
2015年 | 346篇 |
2014年 | 513篇 |
2013年 | 650篇 |
2012年 | 1063篇 |
2011年 | 1076篇 |
2010年 | 598篇 |
2009年 | 598篇 |
2008年 | 957篇 |
2007年 | 951篇 |
2006年 | 891篇 |
2005年 | 790篇 |
2004年 | 714篇 |
2003年 | 637篇 |
2002年 | 656篇 |
2001年 | 94篇 |
2000年 | 87篇 |
1999年 | 112篇 |
1998年 | 109篇 |
1997年 | 112篇 |
1996年 | 93篇 |
1995年 | 75篇 |
1994年 | 72篇 |
1993年 | 65篇 |
1992年 | 52篇 |
1991年 | 48篇 |
1990年 | 43篇 |
1989年 | 40篇 |
1988年 | 32篇 |
1987年 | 24篇 |
1986年 | 32篇 |
1985年 | 15篇 |
1984年 | 37篇 |
1983年 | 30篇 |
1982年 | 21篇 |
1981年 | 22篇 |
1980年 | 18篇 |
1979年 | 11篇 |
1978年 | 11篇 |
1977年 | 18篇 |
1974年 | 11篇 |
1973年 | 10篇 |
1972年 | 9篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
N. S. Hari Narayana Moorthy Sergio F. Sousa Maria J. Ramos Pedro A. Fernandes 《Medicinal chemistry research》2016,25(7):1340-1357
Farnesyltransferase (FTase) is one of the prenyltransferase family enzymes that catalyse the transfer of 15-membered isoprenoid (farnesyl) moiety to the cysteine of CAAX motif-containing proteins including Rho and Ras family of G proteins. Inhibitors of FTase act as drugs for cancer, malaria, progeria and other diseases. In the present investigation, we have developed two structure-based pharmacophore models from protein–ligand complex (3E33 and 3E37) obtained from the protein data bank. Molecular dynamics (MD) simulations were performed on the complexes, and different conformers of the same complex were generated. These conformers were undergone protein–ligand interaction fingerprint (PLIF) analysis, and the fingerprint bits have been used for structure-based pharmacophore model development. The PLIF results showed that Lys164, Tyr166, TrpB106 and TyrB361 are the major interacting residues in both the complexes. The RMSD and RMSF analyses on the MD-simulated systems showed that the absence of FPP in the complex 3E37 has significant effect in the conformational changes of the ligands. During this conformational change, some interactions between the protein and the ligands are lost, but regained after some simulations (after 2 ns). The structure-based pharmacophore models showed that the hydrophobic and acceptor contours are predominantly present in the models. The pharmacophore models were validated using reference compounds, which significantly identified as HITs with smaller RMSD values. The developed structure-based pharmacophore models are significant, and the methodology used in this study is novel from the existing methods (the original X-ray crystallographic coordination of the ligands is used for the model building). In our study, along with the original coordination of the ligand, different conformers of the same complex (protein–ligand) are used. It concluded that the developed methodology is significant for the virtual screening of novel molecules on different targets. 相似文献
2.
Khaled Adil Marija Popovic Fabio L. Cury Sergio L. Faria Marie Duclos Luis Souhami 《Practical radiation oncology》2019,9(1):24-28
Purpose
This study aimed to investigate 3 planning target volume (PTV) margin expansions and determine the most appropriate volume to be used in bladder preservation therapy when using daily cone beam computed tomography (CBCT). We aimed to establish whether a smaller PTV expansion is feasible without risking geographical miss.Methods and materials
The study included patients with bladder cancer who were treated with a hypofractionated course of radiation therapy delivered with intensity modulated radiation therapy. The clinical target volume (CTV) was the whole empty bladder, and the PTV consisted of a 1.5-cm margin around the bladder (PTV1.5 cm). Patients underwent daily CBCT imaging before treatment to assess the bladder volume and ensure accurate positioning. We investigated 2 additional smaller PTV margin expansions to determine the most appropriate volume to be used with CBCT as a daily image guided radiation therapy modality. These margins were created retrospectively on every CBCT. The first additional volume was a uniform PTV margin of the surrounding 1 cm (PTV1 cm). When considering that the majority of the internal bladder movement was due to the variation in filling that occurs in the superior and anterior directions, a second volume of an anisotropic PTV margin with a 1.5-cm superior/anterior and 1 cm in other directions (PTV1/1.5 cm) was created. We recorded the frequency and measured the volume of bladder falling out of each PTV based on the daily CBCT.Results
For the purpose of this study, we considered an arbitrary 5 cm3 of CTV falling out of the designated PTV as a clinically significant volumetric miss. The frequency of such a miss when applying the uniform PTV1 cm was 1%. However, when applying the uniform PTV1.5 cm and anisotropic PTV1/1.5 cm margins, the frequency was 0.5% and 0.5%, respectively.Conclusions
The anisotropic PTV expansion of 1.5 cm superiorly and anteriorly and 1 cm in all other directions around the bladder (CTV) provides a safe PTV approach when daily CBCT imaging is used to localize an empty bladder. 相似文献3.
4.
5.
6.
7.
Lee Mi Jung Romero Sergio Velozo Craig A. Gruber-Baldini Ann L. Shulman Lisa M. 《Quality of life research》2019,28(6):1595-1603
Quality of Life Research - This study investigated the PROMIS Self-Efficacy Measure for Managing Chronic Conditions (PROMIS-SE) domain distributions and examined the factor structure of the... 相似文献
8.
9.
10.
Roberto Manfredi Sergio Sabbatani Leonardo Calza 《The Brazilian journal of infectious diseases》2007,11(6):605-609
A patient with HIV infection developed the first episode of AIDS-defining opportunism (severe Candida albicans esophagitis) with an underlying CD4+ lymphocyte count of 1,025 cells/microL. After treatment with a highly active antiretroviral therapy (HAART), taken with insufficient compliance and leaving a residual viral load, our patient suffered from two relapses of esophageal candidiasis, which occurred three months and seven years later, when his CD4+ lymphocyte count was 930 and 439 cells/microL, respectively, and a viral load slightly above 10(4) copies/mL was still present. Also in the HAART era, Candida esophagitis remains one of the most common AIDS-defining diseases, but a presentation with a concurrent CD4+ count above 1,000 cells/microL remains a rare exception, as well as the two isolated, subsequent relapses, occurred with a CD4+ count ranging from 439 to 930 cells/microL, and a residual HIV viremia due to insufficient adherence to the prescribed HAART regimens. Our case report represents the opportunity to revisit the epidemiology and, especially, the pathogenesis of this opportunistic fungal complication in HIV-infected patients and in other subjects at risk, on the ground of an extensive literature review, and to explore possible alternative supporting factors other than the crude absolute CD4+ lymphocyte count, with emphasis on the possible role of a persisting HIV viremia, and other potential contributing factors. Clinicians engaged with immunocompromised patients and subjects with HIV disease, should be aware that a Candida esophagitis may occur and relapse also when the cell-mediated immunity, as measured by a simple CD4+ cell count, do not show relevant abnormalities. 相似文献